SCOTT LEWIS: Open Payments
NPI 1609847714 · TALLAHASSEE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,112 in 115 payments from 24 companies in 2025. Trend: 2023 $2,297 · 2024 $2,980 · 2025 $3,112
Food & beverage: $2,912Education: $200
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 26 | $596 |
| Janssen Biotech, Inc. | 17 | $561 |
| Ferring Pharmaceuticals Inc. | 11 | $351 |
| PFIZER INC. | 9 | $225 |
| Dendreon Pharmaceuticals LLC | 5 | $144 |
| Endo USA, Inc. | 5 | $116 |
| ACCORD HEALTHCARE, INC. | 3 | $114 |
| Boston Scientific Corporation | 5 | $109 |
| SEAGEN INC. | 1 | $100 |
| Merck Sharp & Dohme LLC | 3 | $95 |
Products named: ERLEADA, GEMTESA, ADSTILADRIN, XTANDI, ORGOVYX, PROVENGE, RYBREVANT, Camcevi.
Industry payments across FL — which companies pay providers there.
